C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/258, 260/245
C07D 265/30 (2006.01) C07D 239/545 (2006.01) C07D 295/00 (2006.01)
Patent
CA 1085842
Abstract of the Disclosure Physiologically-acceptable substituted 1,2-ethylene- diamines and 1,3-propylenediamines, in free-base and in acid- addition-salt form, have highly pronounced and cardioselective .beta.-adrenolytic action, antiarrhythmic action and hypotensive action on administration to humans. The diamines are, more specifically, N-[3-aryloxy-2-hydroxypropyl]-N'-[1,3-(di-R3)- 2,4-dioxypyrimid-6-yl] (ethyle?e or propylene)diamines wherein R3 is -H or lower alkyl and the aryl nucleus is either further unsubstituted, further monosubstituted or further disubsti- tuted. The compounds are prepared e.g., by reacting a corresponding N-[3-phenoxy-2-hydroxypropyl] (ethylene or propylene)diamine with a corresponding 6-chloropyridine- 2,4-dione in a suitable medium containing an acid-binding agent. Such compounds are administered orally or parenter- ally in effective, but substantially non-toxic, doses either in substantially pure form, in virtually any standard dosage form or in combination with one or more other pharamacologi- cally- and chemically-compatible drugs.
303380
Grawinger Otto
Raabe Thomas
Scholtholt Josef
Schraven Eckhard
Cassella Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Alkylenediamine derivatives and processes for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylenediamine derivatives and processes for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylenediamine derivatives and processes for their preparation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-794031